文献速递主动脉疾病

EVAR术后Ia型内漏管理策略结局:系统综述与Meta分析

Type Ia Endoleak Management Strategy Outcomes after Endovascular Abdominal Aortic Aneurysm Repair: A Systematic Review and Meta-analysis.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2026-09-20

总体技术成功率95.2%、临床成功率91.9%,早期死亡率3.5%,随访期间内漏解除维持率96.0%;FBEVAR是最常采用的策略,证据质量极低,治疗选择应个体化。

要点

  • EVAR术后Ia型内漏干预总体技术成功率95.2%,临床成功率91.9%。
  • 早期死亡率3.5%,随访内漏解除维持率96.0%,证据质量极低。

核心结论

  • 在选定病例中T1aEL治疗可行,技术和临床成功率看似可接受。
  • FBEVAR已成为最常采用的干预方式,治疗选择应个体化。

研究设计与样本

  • 纳入标准为报告EVAR术后T1aEL干预结局且队列至少5例患者的研究。
  • 检索MEDLINE(via PubMed)、Scopus、Web of Science和Cochrane Library。
  • 采用GRADE方法评估证据确定性,ROBINS-I v2工具评估研究层面偏倚风险。

主要发现

  • 从初次EVAR到T1aEL矫正的估计平均间隔为47.3个月(95%CI 37.60-56.93个月)。
  • 总体估计技术成功率为95.2%(95%CI 93.9-96.4%),临床成功率为91.9%(95%CI 90.0-93.8%)。
  • 估计总体早期死亡率为3.5%(95%CI 2.7-4.3%)。
  • 随访(平均19.0个月,95%CI 16.11-21.95个月)时96.0%(95%CI 94.6-97.3%)患者维持内漏解除。

关键数值与推荐

  • 开放转换:424例,技术成功率94.7%(95%CI 90.2-98.1%)。
  • 近端延伸:209例,技术成功率97.9%(95%CI 93.9-100%)。
  • 烟囱EVAR:149例,技术成功率94.1%(95%CI 88.8-98.1%)。
  • 栓塞:117例,技术成功率95.4%(95%CI 89.7-99.2%)。

临床怎么用

  • T1aEL治疗应个体化,综合考虑解剖特征、患者体能状态、预期寿命和内漏特异性特征。
  • FBEVAR是最常采用的策略,但需根据具体情况选择开放转换、近端延伸、烟囱EVAR、栓塞等方案。

局限性

  • GRADE分析确定所有结局的总体证据质量极低。
  • 纳入研究均为非随机研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to systematically review and synthesise the available evidence on the management of type Ia endoleak (T1aEL) after endovascular aortic repair (EVAR). DATA SOURCES: MEDLINE (via PubMed), Scopus, Web of Science, and the Cochrane Library. REVIEW METHODS: Studies reporting outcomes of interventions for T1aEL after EVAR were included if they presented cohorts of at least five patients. The certainty of evidence was assessed using the GRADE methodology, while risk of bias was evaluated at the study level using the ROBINS-I v2 tool. RESULTS: Sixty-three non-randomised studies were included, comprising 2 284 patients (89.0% men, 95% confidence interval [CI] 87.4 - 90.5%) with a weighted mean age of 76.2 years (95% CI 75.30 - 77.02 years). GRADE analysis determined the overall quality of evidence for all outcomes to be very low. The estimated mean interval between index EVAR and T1aEL correction was 47.3 months (95% CI 37.60 - 56.93 months). Overall estimated technical success and clinical success were 95.2% (95% CI 93.9 - 96.4%) and 91.9% (95% CI 90.0 - 93.8%), respectively. Of the 2 284 patients, 1 220 patients underwent fenestrated or branched EVAR (FBEVAR) (technical success 94.4%, 95% CI 91.6 - 96.8%), 424 open conversion (technical success 94.7%, 95% CI 90.2 - 98.1%), 209 proximal extension (technical success 97.9%, 95% CI 93.9 - 100%), 149 chimney EVAR (technical success 94.1%, 95% CI 88.8 - 98.1%), 117 embolisation (technical success 95.4%, 95% CI 89.7 - 99.2%), 102 endostaples (technical success 76%, 95% CI 39.3 - 99.3%), and 63 physician modified endografts (technical success 97.8%, 95% CI 94.1 - 100%). The estimated overall early mortality rate was 3.5% (95% CI 2.7 - 4.3%). Endoleak resolution at follow up (mean 19.0 months, 95% CI 16.11 - 21.95 months) was maintained in 96.0% (95% CI 94.6 - 97.3) of patients. CONCLUSION: T1aEL treatment is feasible in selected cases, with apparently acceptable technical and clinical success rates. FBEVAR has emerged as the most frequently adopted approach. Treatment selection should be individualised, taking into account anatomic characteristics, patient fitness, life expectancy, and endoleak specific features.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Di Leo A, Cicala N, Bianchini Massoni C, et al. Type Ia Endoleak Management Strategy Outcomes after Endovascular Abdominal Aortic Aneurysm Repair: A Systematic Review and Meta-analysis. Eur J Vasc Endovasc Surg. 2026. PMID: 42764102. doi:10.1016/j.ejvs.2026.09.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。